Immunogen reported $92.8M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US USD 10.21B 1.08B
Agios Pharmaceuticals AGIO:US USD 90.16M 10.35M
Amgen AMGN:US USD 3.91B 504M
Astellas Pharma 4503:JP JPY 293.65B 54.99B
AstraZeneca AZN:LN USD 9.74B 495M
Bluebird Bio BLUE:US USD 84.85M 24.07M
Bristol Myers Squibb BMY:US USD 8.75B 552M
Eli Lilly And LLY:US USD 5.27B 12.8M
Emergent Biosolutions EBS:US USD 282M 32.7M
Exelixis EXEL:US USD 329.12M 6.6M
Halozyme Therapeutics HALO:US USD 128.4M 10.09M
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Immunogen IMGN:US USD 92.8M 17.59M
Intrexon XON:US USD 24.34M 2.74M
Karyopharm Therapeutics KPTI:US USD 66.98M 15.6M
Macrogenics MGNX:US USD 66.69M 1.13M
Nektar Therapeutics NKTR:US USD 77.93M 96.49M
Novartis NVS:US USD 10.67B 183M
Pfizer PFE:US USD 13.23B 2.41B
Regeneron Pharmaceuticals REGN:US USD 1.71B 34.8M
Seattle Genetics SGEN:US USD 703.1M 72.49M